The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Monday, November 16, 2020
Mesa Biotech has been awarded $13 million from the BARDA for its rapid molecular diagnostic test for detection of SARS-CoV-2 & Flu A/Flu B in a single...
read more
Monday, November 16, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more
Friday, November 13, 2020
Quansys Biosciences announced the FDA has issued an EUA for its laboratory-based IgG antibody test.
read more
Tuesday, November 10, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more
Thursday, November 05, 2020
Qualigen announced written feedback to its Type B Pre-IND meeting request from the FDA that is in general agreement with the Company's planned ...
read more
Thursday, October 29, 2020
Helix has received an expanded EUA from the FDA for the Helix COVID-19 Test.
read more
IncellDx will collaborate on the SARS-CoV2 Clinical Trial NCT04435522 involving Pfizer's FDA-approved CCR5 antagonist Maraviroc.
read more
Thursday, October 22, 2020
Centogene announced the FDA has issued EUA for CentoSure, the company's latest SARS-CoV-2 RT-PCR test.
read more
Thursday, October 22, 2020
DxTerity Diagnostics announced the EUA for their SARS-CoV-2 RT-PCR test, SafeWorkDx.
read more
Novellus has licensed its induced mesenchymal stem cells on a worldwide basis to NoveCite, a newly formed subsidiary of Citius Pharmaceuticals.
read more
Tuesday, October 13, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
Wednesday, September 30, 2020
Leinco has developed a proprietary, fully validated assay termed COVID-19 ImmunoRank Neutralization MICRO-ELISA test.
read more
Tuesday, September 29, 2020
Eiger announced results of an investigator sponsored study of Peginterferon Lambda-1a in outpatients with mild and uncomplicated COVID-19.
read more
Thursday, September 24, 2020
MorphoSys and I-Mab announced the FDA has cleared the IND for antibody MOR210/TJ210 for relapsed or refractory advanced solid tumors.
read more